WARRANTS (Tables)

6 Months Ended

12 Months Ended

Sep. 30, 2018

Mar. 31, 2018

Warrants and Rights Note Disclosure [Abstract]

Schedule Of Share Based Compensation Stock Purchase Warrants Activity [Table Text Block]

The following is a continuity schedule of the Company’s common share purchase warrants:

	Weighted-Average
	Number of Warrants			Exercise Price ($)
Outstanding and exercisable, March 31, 2015		72,157			202.50
Issued		48,171			202.50
Exercised		(992	)		(120.00	)
Outstanding and exercisable, March 31, 2016		119,336			202.50
Exercised		(1,747	)		(120.00	)
Outstanding and exercisable, March 31, 2017		117,589			202.50
Exercised		(33,335	)		(37.50	)
Issued in connection with anti-dilution provision connected to warrant transaction		559			112.35
Issued in connection with anti-dilution provision connected to warrant transaction		6,275			194.00
Issued in connection to the warrant transaction to the broker		2,667			37.50
Issued in connection with the conversion of loans and interest into common shares		106,709			9.375
Issued in connection with the conversion of loans and interest into common shares		15,658			90.00
Issued in connection with anti-dilution provision connected to warrant transaction		136,388			73.02
Issued in connection with anti-dilution provision connected to warrant transaction		13,464			44.28
Outstanding at March 31, 2018		365,974			53.19
Issued in connection with anti-dilution provision connected to warrant transaction		67,952			55.71
Issued in connection with anti-dilution provision connected to warrant transaction		6,305			34.50
Outstanding at September 30, 2018		440,231			44.21

The following is a continuity schedule of the Company’s common share purchase warrants :

				Weighted-Average
	Number of Warrants			Exercise Price ($)
Outstanding and exercisable, March 31, 2015		72,157			202.50
Issued		48,171			202.50
Exercised		(992	)		(120.00	)
Outstanding and exercisable, March 31, 2016		119,336			202.50
Exercised		(1,747	)		(120.00	)
Outstanding and exercisable, March 31, 2017		117,589			202.50
Exercised		(33,335	)		(37.50	)
Issued in connection with anti-dilution provision connected warrant transaction		559			112.35
Issued in connection with anti-dilution provision connected warrant transaction		6,275			194.00
Issued in connection to the warrant transaction to the broker		2,667			37.50
Issued in connection with conversion of loans and interest into common shares		106,709			9.375
Issued in connection with conversion of loans and interest into common shares		15,658			90.00
Issued in connection with anti-dilution provision connected with issuance of common shares		136,388			73.02
Issued in connection with anti-dilution provision connected with issuance of common shares		13,464			44.28
Outstanding and exercisable, March 31, 2018		365,974		$	53.19

Schedule of Common Share Purchase Warrants Outstanding [Table Text Block]

The following is a summary of common share purchase warrants as of September 30, 2018:

Exercise Price ($)		Number of Warrants		Expiry Date
	90.00		15,658	March 31, 2023
	55.71		136,339	February 26, 2019
	55.71		28,531	March 27, 2019
	55.71		7,618	March 31, 2019
	55.71		59,061	April 21, 2019
	55.71		27,883	May 27,2019
	55.71		27,238	June 30, 2019
	34.50		28,527	February 26, 2019
	37.50		2,667	June 27, 2020
	9.375		64,025	August 14, 2022
	9.375		42,684	March 31, 2022
			440,231

The following is a summary of common share purchase warrants outstanding after the warrant offer to amend and exercise the additional warrant issue and the re-pricing of the warrants as of March 31, 2018.

Exercise Price ($)	Number of Warrants		Expiry Date
90.00		15,658	March 31, 2023
73.02		104,019	February 26, 2019
73.02		21,768	March 27, 2019
73.02		5,813	March 31, 2019
73.02		45,061	April 21, 2019
73.02		21,274	May 27, 2019
73.02		20,782	June 30, 2019
44.28		22,223	February 26, 2019
37.50		2,667	June 27, 2020
9.375		64,025	August 14, 2022
9.375		42,684	March 31, 2022
		365,974

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

Exercise Price ($)	Number of Warrants		Expiry Date		Expected life (years)		Risk free rate			Dividend rate			Forfeiture rate			Expected volatility			Remeasured fair value
90.00		15,658		31-Mar-23		5		1.59	%		0	%		0	%		135	%		116,142
73.02		104,019		26-Feb-19		0.92		1.59	%		0	%		0	%		135	%		100,281
73.02		21,768		27-Mar-19		1		1.59	%		0	%		0	%		135	%		24,815
73.02		5,813		31-Mar-19		1		1.59	%		0	%		0	%		135	%		6,769
73.02		45,061		21-Apr-19		1.08		1.59	%		0	%		0	%		135	%		58,358
73.02		21,274		27-May-19		1.16		1.59	%		0	%		0	%		135	%		32,276
73.02		20,782		30-Jun-19		1.25		1.59	%		0	%		0	%		135	%		36,116
44.28		22,223		26-Feb-19		0.92		1.59	%		0	%		0	%		135	%		38,423
9.375		64,025		14-Aug-22		4.38		1.59	%		0	%		0	%		135	%		593,355
9.375		42,684		31-Mar-22		4		1.59	%		0	%		0	%		135	%		387,529
		363,307																		1,394,164

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details